Spring is around the corner, and it won’t be long before it’s prom and graduation seasons for many high schoolers. Rites of passage for many, these are times for teens to celebrate, but can also be times of poor decision-making, especially when vehicles are involved. The National Highway Traffic Safety Administration (NHTSA) reports that 2,524 teen drivers and passengers were killed and 177,000 were injured in 2013. Twenty-seven percent of these fatalities occurred between April and June, according to the Insurance Institute for Highway Safety (IIHS).
“The statistics are staggering, especially when you consider that most of these accidents and fatalities are preventable,” said Randy Petro, Mercury Insurance’s chief claims officer. “We don’t want any families to suffer through the loss of a child, so Mercury is taking action with the launch of the ‘Mercury Insurance Drive Safe Challenge.’”
The Mercury Insurance Drive Safe Challenge kicked off with a free defensive driving program, which included hands-on driving skills training and classroom material. An interactive website provides teens with detailed instruction, as well as gives parents the tools to shape responsible driving behavior.
To view the multimedia release go to:
http://www.multivu.com/players/English/7772251-mercury-teen-drive-safe-challenge/
Medical researchers are making unprecedented progress into understanding why women suffer disproportionately from a number of diseases. Those insights are providing information to help develop medicines to attack diseases such as osteoporosis, multiple sclerosis, depression, rheumatoid arthritis and age-related macular degeneration, all of which affect more women than men.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/50270/
According to a national online survey released today by the Ad Council, only a third of parents in the United States are very concerned that lead poses a health risk to their children. However, lead poisoning affects more than one million children in the United States. If not detected early, children with high levels of lead in their bodies can suffer from damage to the brain and nervous system, behavior and learning problems (such as hyperactivity), slowed growth, hearing problems and aggressive behavior.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/43516/
Life is unpredictable and can be even more so when you have allergies. During this fall allergy season, your runny nose, sneezing or itchy, watery eyes just might earn you top honors in Allegra's new Allergy Adventures contest on Facebook. Allergy sufferers are invited to upload a short video showing their daily challenges with allergies for a chance to win $5,000 toward a fun-filled adventure where they can enjoy life – without worrying about allergies.
Over 40 million adults suffer from indoor and outdoor allergies in the United States. During the fall, many people suffer from allergy triggers such as ragweed and dust mites. The contest is meant to help people say farewell to disruptive allergy symptoms now that fast (starts working at hour one), long-lasting, non-drowsy relief is available over-the-counter from Allegra.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/allegra/50885/
John Frieda® Hair Care invented the frizz-fighting category with Frizz Ease®, the game-changing hair smoother. Gina Rodriguez happens to be really gifted at taming her own naturally wavy, frizz-prone hair. So they’ve teamed up for a new movement – the #FrizzFreeHairGoals campaign – designed to teach women everything they need to know about styling any curl, wave or ringlet.
To kick off the partnership, Rodriguez will appear in a series of engaging how-to videos, to be posted on John Frieda’s social channels starting this month. In each one, the popular young actress tosses vanity out the window, talking openly about her biggest hair issue—frizz—and demonstrating easy ways to achieve the most beautiful, flattering styles of the moment.
“I’ve been a devotee of John Frieda® Frizz Ease® for years,” says Rodriguez. “Since my hair’s naturally wavy, I’ve spent more than my fair share of time fighting frizz. Frizz Ease® is the only thing that can help tame frizz and leave my hair looking smooth, so this partnership feels like a natural fit. I’m excited to have the chance to show women that they don’t have to suffer from frizzy hair forever — there’s a better way to style.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7811051-john-frieda-frizzfreehairgoals-gina-rodriguez/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
The Heroes With Hearing Loss program, sponsored by Hamilton CapTel®, introduces veterans with hearing loss to resources and solutions that best meet their individual and unique needs.
According to Department of Defense statistics, hearing loss is the number one war-related injury affecting veterans from the battlefields of Iraq and Afghanistan. An estimated 60 percent of veterans returning from Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) have some hearing damage, with 840,000 suffering from tinnitus and just over 700,000 suffering from hearing loss. More than 1.2 million veterans from every generation suffer from some form of hearing loss.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62613-heroes-with-hearing-loss-new-program-debuts-vfw-national-convention
Hanes has launched a new men's underwear marketing campaign starring basketball great Michael Jordan in a new television commercial that shows Hanes Lay Flat Collar undershirts will never suffer from wavy
Hanes has launched a new men's underwear marketing campaign starring basketball great Michael Jordan in a new television commercial that shows Hanes Lay Flat Collar undershirts will never suffer from wavy
With the February launch of GOPO® Rosehip with Galactolipids, a natural, plant-based joint care supplement clinically proven to support joint health, the natural supplement is gaining traction and helping millions who suffer joint pain due to age, sports injuries, etc. Used extensively in Europe, GOPO is now available in the U.S. and proven effective in supporting long-term joint mobility and cartilage care.
GOPO Rosehip with Galactolipids is made from 100% specially-cultivated, natural rosehip using a patented extraction process and is the only product of its kind to contain a high level of galactolipids - a key component of the rosehip which may play a valuable role in the care of joints and joint tissues.
To view the multimedia release go to:
http://www.multivu.com/players/English/7918251-new-gopo-joint-care-all-natural-supplement/
Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year¹. In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient’s “treatment toolbox” to address specific types of migraine episodes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zogenix/50344/
For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
